Brawn Biotech P/B Ratio

Current P/B Ratio
2.06
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Brawn Biotech (BRAWN) P/B ratio is 2.06 (Moderate), book value per share ₹10.00 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. Compare with BRAWN DCF valuation to assess whether the stock is under or overvalued.

Current Valuation Metrics

P/B Ratio 2.06
Current Price ₹21.60
Book Value/Share ₹10.00
Exchange BSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹3 Cr
Share Capital ₹3 Cr
Reserves & Surplus ₹0 Cr
Outstanding Shares 3,000,000
Book Value per Share ₹10.00

Valuation Signal

Signal Fairly Valued
Historical Avg 1.22
Historical Range 0.76 - 2.15
Percentile 80.0%

Sector Context

Sector Average -0.94
Sector Median 0.6
Sector Rank #11 of 50
Sector Percentile 22.0%

BRAWN P/B Ratio — Valuation Insights & Book Value Analysis

Brawn Biotech price-to-book ratio interpretation, valuation status and historical context — current P/B 2.06 (Moderate). For live price, earnings yield and the full fundamental profile, see Brawn Biotech share price chart.

  • Current PB is 68.3% above historical average
  • Trading at premium to sector average PB of -0.94

Brawn Biotech P/B Ratio Historical Trend

BRAWN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View BRAWN 52-week performance for the annual high/low range and current price position.

BRAWN Historical P/B Ratio — Book Value Per Share & Year-End Price

Brawn Biotech annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 2.15 ₹10.0 ₹21.51 ₹3 Moderate
2024 1.28 ₹16.67 ₹21.31 ₹5 Moderate
2023 1.09 ₹20.0 ₹21.90 ₹6 Moderate
2022 0.84 ₹23.33 ₹19.70 ₹7 Low
2021 0.76 ₹30.0 ₹22.85 ₹9 Low

BRAWN vs Healthcare Peers — P/B Ratio Comparison

Brawn Biotech P/B 2.06 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.

Sector Average
-0.94
Sector Median
0.6
Lowest P/B
-31.21
Highest P/B
1.03
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -31.21 ₹25 Low
Sun Pharma Advanced Rese… SPARC -16.05 ₹5,310 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.31 ₹75 Low
Parmax Pharma PARMAX -2.16 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.76 ₹121 Low
Cresanto Global CRESANTO -0.7 ₹2 Low